NYSEAMERICAN:CVRS Corindus Vascular Robotics (CVRS) Stock Price, News & Analysis → Biden replacement revealed? (From Paradigm Press) (Ad) Free CVRS Stock Alerts $4.27 0.00 (0.00%) (As of 11/27/2019) Add Compare Share Share Today's Range$4.27▼$4.2750-Day Range N/A52-Week Range$0.78▼$4.40VolumeN/AAverage Volume1.99 million shsMarket Capitalization$891.08 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Corindus Vascular Robotics alerts: Email Address Ad Stansberry ResearchUrgent dollar warningYour 2024 Election Money Blueprint Voters are angrier than ever, and it's likely to keep getting worse. The media and Wall Street keep declaring how great the economy supposedly is... but no one – besides the ultra-rich – seems to feel that way. Protect yourself with this one simple move today.Find out for free here. About Corindus Vascular Robotics Stock (NYSEAMERICAN:CVRS)Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures. Its CorPath system allows the physician to perform procedures with a control console located within an interventional cockpit; and CorPath GRX system enables the precise robotic-assisted control of guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit. The company sells its products through direct sales force, as well as through distributor and partnership relationships. It serves vascular, coronary, peripheral vascular, neurointerventional, and structural heart markets. Corindus Vascular Robotics, Inc. is headquartered in Waltham, Massachusetts.Read More CVRS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CVRS Stock News HeadlinesMarch 22, 2024 | thestreet.comCorindus Vascular Robotics, Inc.February 9, 2024 | benzinga.comHealthCor Partners Fund II, L.P.'s Net WorthMay 2, 2024 | Stansberry Research (Ad)$5,000 Gold?Former Wall Street Banker Reveals Mysterious Gold Leverage As gold continues to soar, this ex-Goldman Sachs VP says DON'T buy bullion or mining stocks. Instead, he's just shared a "gold bank" that uses about $10 of your money to harness the power of two ounces of pure gold (worth about $4,200 right now).May 28, 2023 | forbes.comRobotics, AI And Cognitive Computing Are Changing Organizations Even Faster Than We ThoughtApril 21, 2023 | marketwatch.com2023-2030 Robotic Vascular Catheter System Market Size with [94 Pages] includes Growth Rate Analysis | New Report by Absolute ReportsMarch 2, 2023 | techcrunch.comRobotics & AIJanuary 29, 2023 | finance.yahoo.comGanymed Robotics Raises Additional €15 M through Series B Extension Bringing Total Amount to €36 MJanuary 17, 2023 | finance.yahoo.comThe Worldwide Industrial Robotics Industry is Expected to Reach $43.9 Billion in 2027May 2, 2024 | Stansberry Research (Ad)$5,000 Gold?Former Wall Street Banker Reveals Mysterious Gold Leverage As gold continues to soar, this ex-Goldman Sachs VP says DON'T buy bullion or mining stocks. Instead, he's just shared a "gold bank" that uses about $10 of your money to harness the power of two ounces of pure gold (worth about $4,200 right now).January 5, 2023 | finance.yahoo.comMonopoly Dreams(TM) and Novelte Robotics Join Forces to Pamper Visitors with Interactive Information & Tour Guide Service - RoboButlerOctober 9, 2022 | finance.yahoo.comRobotics as a Service (RaaS) Market to record USD 1.23 Bn incremental growth -- Driven by changes in the global labor forceSeptember 12, 2022 | apnews.comCorindus, A Siemens Healthineers Company, Announces Study Results Demonstrating Safety and Effectiveness of CorPath® GRX Neurovascular SystemAugust 30, 2022 | investing.comCVRS_old Historical DataApril 13, 2022 | finance.yahoo.comCorindus Announces New Office Opening in Newton to Support GrowthJanuary 5, 2022 | investing.comCorindus Vascular Robotics Inc (CVRS_old)November 11, 2021 | apnews.comIMPULSE DYNAMICS APPOINTS FIVE NEW BOARD MEMBERSSee More Headlines Receive CVRS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Corindus Vascular Robotics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/07/2018Today5/02/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Medical Appliances & Equipment Sub-IndustryN/A Current SymbolNYSEAMERICAN:CVRS Previous SymbolNYSEMKT:CVRS CUSIPN/A CIKN/A Webwww.corindus.com Phone+1-508-6533335FaxN/AEmployees90Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares208,685,000Free FloatN/AMarket Cap$891.08 million OptionableNot Optionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Mark J. Toland (Age 49)CEO, Pres & Director Mr. David W. Long (Age 49)CFO, Sr. VP, Sec. & Treasurer Mr. Douglas Teany (Age 47)Chief Operating Officer Ms. Nora DuttaSr. VP of HRDr. J. Aaron GranthamChief Medical Officer of CardiovascularKey CompetitorsMiMedx GroupNASDAQ:MDXGRelay TherapeuticsNASDAQ:RLAYViridian TherapeuticsNASDAQ:VRDNTyra BiosciencesNASDAQ:TYRAEyePoint PharmaceuticalsNASDAQ:EYPTView All Competitors CVRS Stock Analysis - Frequently Asked Questions How were Corindus Vascular Robotics' earnings last quarter? Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) released its quarterly earnings data on Tuesday, August, 7th. The medical equipment provider reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by $0.01. The medical equipment provider had revenue of $1.67 million for the quarter, compared to the consensus estimate of $3 million. What other stocks do shareholders of Corindus Vascular Robotics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Corindus Vascular Robotics investors own include Amarin (AMRN), Advanced Micro Devices (AMD), Micron Technology (MU), Alibaba Group (BABA), Helios and Matheson Analytics (HMNY), NVIDIA (NVDA), TherapeuticsMD (TXMD), Ambarella (AMBA) and Exelixis (EXEL). How do I buy shares of Corindus Vascular Robotics? Shares of CVRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEAMERICAN:CVRS) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithNew Trump BombshellThe Freeport SocietyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTrump just won 2024Porter & CompanyHe Is Giving Away BitcoinCrypto Swap Profits4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corindus Vascular Robotics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
